Delivery Order SPE2DB20D1100-SPE2DB25FC0C9
Award Date
4/29/25
Potential Completion Date
4/30/25
Potential Value
$5.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FG0XA, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,185.79 firm fixed-price delivery order is for the supply of 4,568,013,055 units of the drug Febuxostat 40 mg tablets. The contract has an ultimate completion date of April 24, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a $1,518.00 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4,565,497,445 units of Febuxostat 40 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,044.95 firm fixed-price delivery order is for the supply of febuxostat 40 mg tablets. The contract has an ultimate completion date of October 28, 2024 and was awarded on October 25, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,563,649,540 units of Febuxostat 40 mg tablets. The Firm Fixed Price delivery order, valued at $1,222.02, has a ceiling of $1,222.02 and a period of performance through February 14, 2024. The contract does not have a set-aside designation, indicating open competition. This award is likely part of a larger Indefinite Delivery Contract (IDC)...
The federal contract award, SPE2DB20D3505|SPE2DB22FT9R2, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,138.59 delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, for the supply of Febuxostat 40 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of June 28, 2022. This award is associated with Amerisourcebergen's...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $2,255.44 to provide the drug Febuxostat 40 mg Tablet 30s. The contract has an ultimate completion date of February 14, 2024 and was awarded on February 13, 2024 by the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,064.52 firm fixed-price delivery order is for the supply of 4567557705 ! FEBUXOSTAT 40 MG TABLET 30S. The contract has an ultimate completion date of March 13, 2025 and was awarded on March 12, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $3,479.78 Firm Fixed Price delivery order is for the supply of 4,565,481,718 units of the prescription medication Febuxostat 40 mg tablets. The contract has an ultimate completion date of August 19, 2024. AmerisourceBergen has been awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,358.43 firm fixed-price delivery order is for the supply of 4559470354 - Febuxostat 40 mg Tablets, 30s. The award has an ultimate completion date of December 30, 2022 and was made on December 29, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,338.63 firm fixed-price delivery order is for the supply of Febuxostat 40 mg tablets, with a completion date of September 9, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...